Cardio Diagnostics Holdings, Inc.
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
CDIO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US56168P2039 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 311 W. SUPERIOR STREET, 60645 CHICAGO
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in artificial intelligence-driven cardiovascular medicine. The company develops and commercializes clinical tests that utilize a proprietary combination of epigenetics, genetics, and AI to enable the early detection and prevention of heart disease. Its core mission is to make cardiovascular care more accessible, personalized, and precise. By analyzing genetic and epigenetic markers, Cardio Diagnostics provides deep insights into an individual's risk of a heart attack, empowering healthcare providers with actionable intelligence for proactive and personalized patient management.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cardio Diagnostics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cardio Diagnostics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cardio Diagnostics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
